Matthew A. Gibbs
General Partner
Boston, MA
mgibbs@oxbio.com
|
Matthew Gibbs is a General Partner of Oxford Bioscience Partners and Oxford Energy Partners, the energy focused affiliate fund of Oxford, a Billion dollar venture capital firm. Mr. Gibbs joined Oxford in 1997 and became a General Partner in 2005. Mr. Gibbs has over 17 years of venture capital experience.
Mr. Gibbs leads the energy initiative at Oxford with investments in Luca Technologies, microbial generated natural gas from coal and Glori Energy, a next generation oil Company. Non-energy investments include Zone Labs, firewall/spyware security software acquired by Checkpoint Software for $290M; eSionic, proprietary molecular systems for the energy storage market; Cambrios, electronic materials for touch display industry; Biosource, research tools and kits acquired by Invitrogen for $130M and Stratagene, analytical instruments acquired by Agilent for $250M.
Prior to joining Oxford, Mr. Gibbs was with the Venture Fund of Washington a venture capital firm. In 1994, Mr. Gibbs was with MedVest, Inc a venture capital syndicated fund with Oak Investment Professionals and Johnson and Johnson Development Corp. Mr. Gibbs received his B.A. from the University of Colorado and completed Executive Programs at Harvard Business School. Mr. Gibbs lives in Boston with his wife and twin daughters.
Back to OBP Team
|